PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Chronic Granulomatous Disease
![PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Chronic Granulomatous Disease](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/8bf2b20a450f0bdef3978317f49fd90d.jpg)
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood on December 14, 2023, titled "Genotype, oxidase status,...
mostra di piùRead the paper here: https://ashpublications.org/blood/article-abstract/142/24/2105/497415/Genotype-oxidase-status-and-preceding-infection-or?redirectedFrom=fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Informazioni
Autore | RDCRN |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company